Startup profile for BRAMI: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

BRAMI funding, valuation and investors

High-protein Mediterranean pasta from lupini beans — NYC consumer brand.

Keep track of BRAMI

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$33M · May 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$33M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · New York, NY

Investors in latest funding

Other: Lerer Hippeau

Sources: latest funding · morningstar.com Last verified: 2026-07-25

Overview

BRAMI makes Mediterranean-inspired high-protein pasta from lupini beans, sold in national retail. VMG Partners led a $33M Series B in May 2026 with La Molisana, Pentland Ventures, Lerer Hippeau, and Gather Ventures participating — roughly $43.8M total equity per AlleyWatch. The round funds manufacturing capacity, supply chain, and U.S. expansion.

Why BRAMI is interesting

CPG investors fund repeat purchase and margin after promo — BRAMI's Series B from VMG signals protein pasta survived Whole Foods/Walmart trials.

Product & use cases

Shelf-stable and fresh pasta products with elevated protein from lupini beans, positioned as better-for-you Italian-style staples.

  • High-protein household pasta meals
  • Retail expansion in grocery chains
  • DTC and omnichannel brand growth

Key facts

  • Series B (May 2026): $33M led by VMG Partners
  • ~$43.8M total equity per AlleyWatch
  • Lerer Hippeau participant
  • NYC HQ consumer brand

Funding history (newest first)

Investors in our directory

Funds linked from BRAMI's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: VMG growth equity validation and Lerer Hippeau NYC consumer network.

Protein pasta is crowded on shelf; BRAMI must defend velocity and gross margin post-promo — VMG due diligence implies metrics passed retail trials.

  • Barilla / De Cecco incumbent

    Traditional pasta giants adding protein lines.

  • Chickpea/lentil pasta brands direct

    Better-for-you pasta aisle competitors.

  • Homemade protein meals alternative

    Non-pasta protein sources.

Notable stories

  • PR Newswire May 2026: VMG leads protein pasta scale-up — supply chain and national retail focus.
  • VCT: May 2026 reminder not every headline was AI — food growth equity still active.

Industries

Market / IPO context

Editorial / static context — not a live quote.

Related funding articles

Venture Capital Tracker pieces that cover BRAMI's financing or category context.

FAQs about BRAMI

Practical answers founders, operators, and investors typically search for.

High-protein Italian-style pasta from lupini beans.
$33M Series B May 2026; ~$43.8M total.
VMG Partners — not in VCT directory.
Lerer Hippeau participated. See /fund/lerer-hippeau.
New York City per VCT.
Both protein-forward pasta; different base ingredients and brand positioning.
National expansion focus post-Series B.
Private; VMG growth rounds imply retail velocity targets.
Legume base for BRAMI's protein pasta formulation.
Consumer macro trend toward higher-protein convenient meals.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.